אימנד 150 מ"ג IV

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Mevcut itibaren:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodu:

A04AD12

Farmasötik formu:

POWDER FOR SOLUTION FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

MERCK SHARP & DOHME B.V, HOLLAND

Terapötik grubu:

APREPITANT

Terapötik endikasyonlar:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Yetkilendirme tarihi:

2011-11-01